Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalClinical Infectious Diseases
Early online date8 Aug 2020
Publication statusE-pub ahead of print - 8 Aug 2020

Cite this